Influence of Specific Collagen Peptides on Recovery After Exercise Induced Muscle Damage

August 23, 2023 updated by: Daniel König, University of Vienna

Influence of Specific Collagen Peptides on Parameters of Biomechanical and Systemic Recovery After Exercise-induced Muscle Damage

The present study aims at investigating the potential influence of specific collagen peptides on recovery after exercise induced muscle damage with focus on long-term effects.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vienna, Austria, 1150
        • University of Vienna, Institute of Sport Science

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • No subjective symptoms during physical exertion
  • Stable weight and dietary behaviour
  • Body Mass Index (BMI) between 18.5 and 24.9
  • No extensive strength/endurance sports so far (less than 3 h/week)
  • No complaints during strenuous physical activity

Exclusion Criteria:

  • Circumstances that impair/prevent sporting activity (e.g. chronic heart disease, arrhythmia, heart valve disease, arthritis etc.)
  • Intolerance/aversion to animal protein
  • Arterial hypertension (high blood pressure) (syst > 200 mmHg and/or diast > 105 mmHg) at rest
  • Presence of insulin-dependent diabetes mellitus
  • Liver and/or kidney disease that precludes a high protein load
  • Collagen supplementation or regular intake of other dietary supplements in the last 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Collagen
15g of collagen peptides ingested daily
Participants ingest 15 grams of either specific collagen peptides or Placebo daily
Both arms undergo a 12-week trainingintervention 3x/week
Placebo Comparator: Placebo
15g of Placebo ingested daily
Both arms undergo a 12-week trainingintervention 3x/week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in maximal voluntary contraction (MVC)
Time Frame: Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)
Measured by isokinetic dynamometer
Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)
Change in rate of force development (RFD)
Time Frame: Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)
Measured by isokinetic dynamometer
Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)
Change in countermovement jump height (CMJ)
Time Frame: Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)
Measured by force plate
Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)
Change in subjective pain score
Time Frame: Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)
Measured by visual analogue scale
Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)
Change in Achilles tendon cross-sectional area
Time Frame: Baseline and after 12 weeks
Measured by ultrasound
Baseline and after 12 weeks
Change in Vastus Lateralis fibre length
Time Frame: Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)
Measured by ultrasound
Baseline (pre, post, 24 hours, 48 hours) and after 12 weeks (pre, post, 24 hours, 48 hours)
Change in collagen related blood markers
Time Frame: Baseline (pre, post, 2 hours, 24 hours, 48 hours) and after 12 weeks (pre, post, 2 hours, 24 hours, 48 hours)
Measured by blood analysis
Baseline (pre, post, 2 hours, 24 hours, 48 hours) and after 12 weeks (pre, post, 2 hours, 24 hours, 48 hours)
Change in Achilles tendon echo intensity
Time Frame: Baseline and after 12 weeks
Measured by ultrasound
Baseline and after 12 weeks
Change in Vastus Lateralis echo intensity
Time Frame: Baseline and after 12 weeks
Measured by ultrasound
Baseline and after 12 weeks
Change in body composition parameters (fat mass, fat-free mass, extracellular mass, body cell mass)
Time Frame: Baseline and after 12 weeks
Measured by bioelectrical impedance analysis
Baseline and after 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Daniel Koenig, Prof. Dr., University of Vienna, Institute of Sport Science

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 28, 2022

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

January 28, 2022

First Submitted That Met QC Criteria

January 28, 2022

First Posted (Actual)

February 2, 2022

Study Record Updates

Last Update Posted (Actual)

August 28, 2023

Last Update Submitted That Met QC Criteria

August 23, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 00765

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Recovery

Clinical Trials on Collagen

3
Subscribe